Skip to content

4Accepted Feb 17, 7:23 PM ET

Nazak Michael Adrian 4

ANTXAN2 Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

7:23 PM

Feb 17, 2023

Filed

Feb 17, 2023

Documents

1

Size

5.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.